Article

Dana-Farber Leads Kadcyla ATEMPT Study in HER2-Positive Breast Cancer

Experts review an innovative study, called the ATEMPT study, which looks at adjuvant T-DM1 in women with HER2-positive breast cancer.

Experts review an innovative study, called the ATEMPT study, which looks at adjuvant T-DM1 in women with HER2-positive breast cancer.

Related Videos
Image of a man in a suit.
Image of woman with brown hair.
Image of a man with short hair, wearing a buttoned-up shirt.
Image of a man with short black hair.
Image of a woman with tied back hair, wearing pearl earrings.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a man with short black hair.
Image of man with gray hair.
Image of woman with black hair.
Image of a man wearing a black suit and tie.
Related Content
Picture of Dr. Guillermo Garcia-Manero
September 18th 2024

Why Transfusion Independence Matters for Patients With MDS

Alex Biese
An expert explained the burden that red blood cell transfusions can place on patients with MDS.
Illustration of a woman with long blonde hair, wearing sunglasses.
August 26th 2024

8 Things to Do While in the Hospital for Cancer Treatment

Mary Sansone
While spending weeks in the hospital for acute myeloid leukemia, I tried eight fun things to keep me busy.
Image of a man wearing a light blue polo shirt.
July 18th 2024

Radiation a Curative-Intent Option in NSCLC and Interstitial Lung Disease

Alex Biese
For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown.
Illustration of a man with a dark beard with rectangular glasses.
July 9th 2024

13 Things I’ve Learned in 2 Years With 2 Cancer Types

Burt Rosen
I was diagnosed with kidney cancer and pancreatic neuroendocrine tumors two years ago, but I’ve learned a lifetime of lessons since.
Dr. Rahul Banerjee in an interview with CURE
June 19th 2024

Double Stem Cell Transplant Feasible for Some With Multiple Myeloma

Alex Biese
One expert explains why double autologous stem cell transplantation is a viable alternative to back-to-back transplant in high-risk multiple myeloma.
Sharing Breast Cancer Experiences is the ‘Most Special Thing’
June 12th 2024

Sharing Breast Cancer Experiences is the ‘Most Special Thing’

Ashley Chan
Having social media platforms to share breast cancer experiences changes the narrative for others who may empathize, a survivor and advocate said.